Tiziana Life Sciences Ltd (NASDAQ:TLSA) Financings

Tiziana Life Sciences Ltd

Financings

RaiseDate
Registered direct offering of ordinary shares
Closed: US$8.8M raised · US$1.25 a share · 1 warrant at US$1.5
Buyers: Ivor Elrifi (2,400,000 ordinary shares, bringing his total holding to 2,757,848 ordinary shares); Gabriele Cerrone (through Panetta Partners Ltd) (1,600,000 ordinary shares, bringing his total holdings to 44,974,830 ordinary shares)
Insiders: Led by CEO Ivor Elrifi, who bought 2,400,000 shares; Executive Chairman Gabriele Cerrone bought 1,600,000 shares through Panetta Partners Ltd
Use of proceeds: Complete Phase 2 na-SPMS and MSA clinical trials and achieve top line data readouts in both
Jan 16, 2026
Public offering of common shares
Cancelled: public offering
Dec 15, 2025

Read by 6ix AI from the company's releases